Kiniksa Pharmaceuticals International Newsroom

Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means

Barron's01:30 ET

Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'

Benzinga22:19 ET

10 Health Care Stocks Whale Activity In Today's Session

BenzingaMay 5 13:35 ET

Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?

BenzingaMay 4 11:46 ET

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $2,347,335, According to a Recent SEC Filing

MT NewswiresMay 2 04:04 ET

3 Stocks Including Kiniksa Pharmaceuticals International That May Be Priced Below Intrinsic Value Estimates

Yahoo FinanceMay 1 07:38 ET

An Intrinsic Calculation For Kiniksa Pharmaceuticals International, Plc (NASDAQ:KNSA) Suggests It's 41% Undervalued

Yahoo FinanceApr 30 06:38 ET

Jefferies Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $45

Moomoo NewsApr 30 03:32 ET · Ratings

Kiniksa Pharmaceuticals Announces GRAMMY Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis

Kiniksa PharmaceuticalsApr 30 00:00 ET

Kiniksa Pharmaceuticals Price Target Raised to $45.00/Share From $40.00 by Jefferies

Dow JonesApr 29 18:03 ET · Ratings

Kiniksa Pharmaceuticals Analyst Ratings

BenzingaApr 29 17:53 ET · Ratings

Kiniksa Pharmaceuticals International | 10-Q: Q1 2025 Earnings Report

SECApr 29 16:16 ET · Announcements

Earnings Call Summary | Kiniksa Pharmaceuticals International(KNSA.US) Q1 2025 Earnings Conference

moomoo AIApr 29 15:25 ET · Conference Call

Wedbush Raises Price Target on Kiniksa Pharmaceuticals to $36 From $34, Maintains Outperform Rating

MT NewswiresApr 29 12:56 ET · Ratings

$KNSA Stock Is up 18% Today. Here's What We See in Our Data.

Quiver QuantitativeApr 29 11:31 ET

Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday

BenzingaApr 29 10:36 ET

Kiniksa Pharmaceuticals Swings to Q1 Net Income, Revenue Increases

MT NewswiresApr 29 08:50 ET

Kiniksa Pharmaceuticals International | 8-K: Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution

SECApr 29 07:40 ET · Announcements

Express News | Kiniksa Pharmaceuticals International PLC: Expects 2025 Arcalyst Net Product Revenue of Between $590 Million and $605 Million

ReutersApr 29 07:39 ET

Kiniksa Pharmaceuticals Raises FY2025 Sales Guidance From $560.00M-$580.00M to $590.00M-$605.00M Vs $698.99M Est

BenzingaApr 29 07:33 ET